How Ingestible Pills Are Revolutionizing Our Understanding of the Gut
Imagine trying to understand a bustling city by only looking at its landfill. You might learn something about what its residents consume and discard, but you'd miss the vibrant, dynamic interactions happening in the different neighborhoods—the financial districts, cultural centers, and residential areas that make each city unique. For decades, this has been precisely the challenge facing scientists trying to understand the human gut microbiome: we've been limited to studying the "landfill"—the stool—while the vibrant microbial "neighborhoods" of our small intestine remained largely inaccessible 2 8 .
The small intestine is approximately 22 feet long in adults—about the height of a two-story building!
The small intestine, a winding tube approximately 22 feet long in adults, has long been terra incognita in the human body. Sandwiched between the stomach and colon, it's where most nutrient absorption occurs and where countless interactions between our bodies and microbes take place. Yet traditional sampling methods have failed to capture this environment under normal, functioning conditions. That is, until now. Recent breakthroughs in ingestible medical devices are finally allowing scientists to explore this mysterious territory, revealing discoveries that are reshaping our understanding of health and disease.
Average length of the adult small intestine
In the colon vs 10³ in the duodenum
For most of microbiome science's history, researchers have relied heavily on fecal samples as proxies for the gut environment. While stool samples are easy to collect and non-invasive, they come with significant limitations. As one research team noted, "The fecal microbiome is dominated by four phyla: Bacillota, Bacteroidota, Actinomycetota, and Pseudomonadota" but this composition differs dramatically from what exists upstream in the small intestine .
The gastrointestinal tract hosts dramatically different environments from section to section, each with unique microbial communities adapted to specific conditions.
The first and shortest section, where partially digested food from the stomach mixes with bile and pancreatic enzymes.
Bacterial concentration: ~10³ per gram
The middle section where most nutrients are absorbed.
Bacterial concentration: ~10⁴-10⁵ per gram
The final section that connects to the large intestine, specializing in absorbing vitamin B12 and other remaining nutrients.
Bacterial concentration: ~10⁷ per gram
| Method | Advantages | Disadvantages |
|---|---|---|
| Stool Sample | Non-invasive, easy to collect, suitable for large studies | Does not represent upper gut regions, misses spatial variation |
| Endoscopy | Direct access to specific regions, can collect both tissue and fluid | Invasive, requires fasting/sedation, expensive, alters normal physiology |
| Ingestible Capsules | Samples during normal digestion, accesses hard-to-reach areas, non-invasive | Device retrieval required, limited sample volume, potential transit delay |
Traditional endoscopic procedures require patients to fast and be sedated, which alters the very environment scientists want to study 2 . As the developers of one new device explained, "The invasive nature of sample collection for studying the small intestinal (SI) microbiome often results in its poor characterization" 1 . This sampling problem has left critical gaps in our understanding of how the gut microbiome influences everything from immune function to neurological health.
The latest generation of ingestible sampling devices reads like something from science fiction—miniature laboratories that patients can swallow, which then travel through the digestive system, collecting precious samples along the way. These devices bypass many limitations of previous methods by sampling intestinal contents during normal digestion, without requiring sedation or significantly altering daily activities 2 .
The device is housed in a gastro-resistant capsule that survives the harsh acidic environment of the stomach.
Once the capsule reaches the small intestine, specific triggers (like pH changes or timing mechanisms) cause it to open.
The device collects intestinal fluid containing microbes, proteins, metabolites, and other molecules of interest.
The device continues through the digestive tract and is retrieved from stool, after which samples are extracted for analysis.
One particularly innovative device, described in a 2023 Nature paper, features a hollow capsule enclosing a bladder that sucks in samples. "Various versions of the capsule open at different pH levels," allowing researchers to sample multiple regions of the small intestine based on the decreasing acidity along the tract 7 .
This device can collect up to 400 microliters of luminal contents—enough for comprehensive multi-omics analyses 2 .
Another design from Pelican Health takes a different approach, containing three separate modules within a single capsule, allowing for multiple samples from the small intestine. This device uses a porous polymer protected by dissolvable walls and contains no electronics, making it simpler and potentially more cost-effective to produce .
Example of an ingestible medical device for gut sampling
In a groundbreaking study published as a preprint in 2025, researchers conducted what's known as a "monocentric interventional trial" (registered as NCT05477069) involving 15 healthy volunteers 1 5 . The study was designed to evaluate both the safety and performance of a novel ingestible medical device for sampling the small intestine.
Healthy Volunteers
Max Retrieval Time
Analysis Methods
Novel Species Found
The findings from this and similar studies have revealed just how different the small intestine is from what we've previously assumed based on stool samples alone.
| Characteristic | Small Intestine | Feces |
|---|---|---|
| Species Richness | Lower | Higher |
| Alpha Diversity | Reduced | Greater |
| Key Metabolites | Bile acids, Amino acids | Short-chain fatty acids |
| Inter-individual Variability | High | Moderate |
| Dominant Bacterial Groups | Lactobacillus, Clostridium, Streptococcus | Bacteroidota, Bacillota |
"Prophage induction was more prevalent in the intestines than in stool" 2 . Prophages are viral DNA embedded in bacterial genomes that can activate and initiate viral replication, potentially influencing microbial community dynamics. This suggests virus-bacteria interactions may play different roles in various gut regions.
This comprehensive toolkit enables researchers to move from simply cataloging which microbes are present to understanding what they're doing and how they're interacting with each other and our bodies. The combination of these approaches—rather than relying on any single method—has been key to recent breakthroughs.
| Tool Category | Specific Examples | Function/Purpose |
|---|---|---|
| Sampling Devices | pH-triggered capsules, Time-delayed capsules, Multi-module devices | Collect intestinal fluid from specific regions during normal digestion |
| Molecular Analysis | Metagenomic sequencing, LC-MS/MS metabolomics, 16S rRNA sequencing | Identify microorganisms and their functions, measure metabolic products |
| Cultural Methods | High-throughput culturomics, Anaerobic culture systems | Grow and identify live microorganisms, discover novel species |
| Bioinformatics Tools | Microbiome analysis pipelines, Metabolite identification software | Process and interpret complex multi-omics datasets |
| Sample Preservation | RNA later, Cryopreservation solutions, Anaerobic transport media | Maintain integrity of samples between collection and analysis |
Sequencing the genetic material of all microorganisms present
Identifying and measuring small molecules and metabolic products
Attempting to grow and identify live microorganisms using culture techniques
The ability to sample the small intestine under physiological conditions opens up exciting possibilities for both research and clinical medicine. Unlike stool samples, which provide a blended, end-stage view of gut processes, these new devices allow scientists to observe the gut environment where most digestion and nutrient absorption actually occurs.
"I think the magic of our capsule is that it is going to transform how people think about the gut microbiota's relationship to diseases" 7 .
These ingestible samplers represent just the beginning. Future devices might be able to sample specific gut regions even more precisely, measure real-time chemical changes, or even deliver interventions exactly where they're needed based on the conditions they detect.
The development of ingestible sampling devices has opened a window into one of the last unexplored frontiers of the human body. By revealing the dramatic differences between the small intestine and stool, these clever gadgets are challenging long-held assumptions about our inner ecosystem. The small intestine isn't merely a waystation between the stomach and colon—it's a unique, dynamic environment with its own microbial residents and metabolic signature.
As this technology continues to evolve, it promises to deepen our understanding of the intricate relationships between our bodies, our microbes, and our health. Each swallowed capsule carries with it the potential to discover new microbial species, unravel complex metabolic pathways, and ultimately develop more effective ways to maintain health and treat disease. The fantastic voyage through our inner landscape has just begun, and the discoveries ahead are sure to be as fascinating as the journey itself.